Goods and Services Tax (GST) is a major tool for improving ease of doing business in India. It is considered as the biggest tax reform since the time of Independence, and will subsume excise and service tax, and various other local levies including VAT. The passing of this bill has grabbed the attention across all […]
The “Internet of things” (IoT) is becoming an increasingly growing topic of conversation both in the workplace and outside of it. It’s a concept that not only has the potential to impact how we live but also how we work. The internet of things (IoT) is the internetworking of physical devices, vehicles, buildings and other items embedded with electronics, software, sensors, actuators, […]
We all want safe and effective medicines to reach patients as soon as possible, but as we know, drug development, market authorization and payer assessment are all slow sections of a long and drawn out journey for a drug. But what if patients could have access to medicines not just months earlier, but potentially 8 […]
All branded drugs are of good quality – Fiction Majority of the branded drugs are of good quality – Fact All generic drugs are of good quality – Fiction Majority of the generic drugs are of good quality – Fact All pharma companies take pro-patient initiatives – Fiction Few pharma companies take pro-patient initiatives – […]
Bioresorbable stents have effectively been pulled from the European market by Abbott and will now be available only in “clinical registry setting at select sites/institutions” in Europe, where they will be monitored till a review in 2018. India has been among the largest markets for these stents in recent years. The development comes in the […]
According to the World Health Organization (W.H.O), there is currently no universally agreed definition among its member states in what is widely known as ‘Counterfeit medicines’. Nevertheless, W.H.O does indicate that the term ‘counterfeit’ is widely used to include falsified, unlicensed, falsely packaged, stolen and substandard medical products. Jurisdictions across the world define counterfeit medicines […]
Healthcare decision making is usually characterized by a low degree of transparency. The demand for transparent decision processes can be fulfilled only when assessment, appraisal and decisions about health technologies are performed under a systematic construct of benefit assessment. The benefit of an intervention is often multidimensional and, thus, must be represented by several decision […]
Clinical research includes the traditional prospective clinical trials, cohort studies, and case-control studies, while outcomes research (OR) has now solidified itself as a separate class of clinical research. OR is an evolving and critical part of health sciences research due to its focus on the improvement of patient care in the practice setting. Evidence included […]
In many parts of the world, the value of medicines is measured by a unit called ‘Quality-Adjusted Life Year’ (QALY), a metric that health economists and others use to quantify the health benefits generated by a particular treatment. QALYs are often used by state-run health systems in many countries to help decide which drugs to […]
